DEB-TACE Prior to Liver Transplantation in the Treatment of HCC
Conditions: Liver Cancer Interventions: Procedure: DEB-TACE Sponsors: RenJi Hospital; Boston Scientific Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
Comparative Health Status and Quality of Life of Patients With Sickle Cell Disease (SCD) Who Underwent Matched-sibling Hematopoietic Stem Cell Transplantation Versus Non Transplanted SCD Case-control Patients
Conditions: Sickle Cell Disease Interventions: Other: Spermogram; Other: Hospital Anxiety and Depression Scale (HADS); Other: SF36 Quality of life questionnaire; Other: Psychologist interview; Other: Optional sera banking; Other: Optional DNA banking Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
A placebo-controlled, crossover trial to investigate the efficacy of tiotropium bromide or placebo added to usual care in stable symptomatic post-hematopoietic stem cell transplantation (HSCT) bronchiolitis obliterans syndrome (BOS)
This study was approved by the Research Ethics Committees of Imam Khomeini Hospital Complex, Tehran University of Medical Science. Recruitment started in September 2022, with 20 patients randomized. The treatment follow-up of participants with tiotropium is currently ongoing and is due to finish in April 2024. The authors will disseminate the findings in peer-reviewed publications, conferences, and seminar presentations.Trial registrationIranian Registry of Clinical Trial (IRCT) IRCT20200415047080N3. Registered on 2022 –07-12, 1401/04/21. (Source: Trials)
Source: Trials - April 6, 2024 Category: Research Source Type: clinical trials
Washed Microbiota Transplantation for Rhinitis
Conditions: Rhinitis Interventions: Drug: Washed Microbiota Transplantation Sponsors: The Second Hospital of Nanjing Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
Tacrolimus Exposure in Kidney Transplantation
Conditions: Kidney Transplant Rejection Sponsors: Seoul National University Hospital; Astellas Pharma Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
The Transplant Cohort of the German Center for Infection Research
Conditions: Infections; Transplant Complication; Transplant Failure; Immunosuppression Sponsors: Technical University of Munich; Hannover Medical School; University Hospital Heidelberg; Universit ät Tübingen; Klinikum der Universität München; Max von Pettenkofer-Institut München; Nierenzentrum Heidelberg; Helmholtz Centre for Infection Research Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation
Conditions: Newly Diagnosed Multiple Myeloma; Multiple Myeloma; Autologous Stem Cell Transplantation Interventions: Biological: Daratumumab; Drug: Lenalidomide; Drug: Bortezomib; Drug: Dexamethasone Sponsors: UNC Lineberger Comprehensive Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
Low-dose Arginine-vasopressin Supplementation on Post-transplant Acute Kidney Injury After Liver Transplantation (AVENIR Trial)
Conditions: Acute Kidney Injury Post Liver Transplantation Interventions: Drug: Arginine vasopressin; Drug: Norepinephrine Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
Assessment of Volatile Organic Compounds (VOC) for the Diagnosis of Invasive Aspergillosis (IA) in Lung Transplant Recipients
Conditions: Invasive Aspergillosis Sponsors: Owlstone Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer
Conditions: Advanced Gastric Cancer Interventions: Procedure: Fecal Microbiota Transplantation Capsules; Procedure: Placebo Sponsors: Xiangyu Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
Conditions: Splenomegaly; Myelofibrosis Interventions: Drug: Ruxolitinib; Procedure: Allogeneic Stem Cell Transplantation; Drug: Levetiracetam; Drug: Eltrombopag; Drug: Busulfan; Drug: Romiplostim; Drug: Fludarabine phosphate; Drug: Cyclophosphamide; Drug: Mesna; Drug: Tacrolimus Sponsors: M.D. Anderson Cancer Center; Incyte Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
Molecular Landscape of Microvascular Inflammation in Kidney Allografts
Conditions: Kidney Rejection Transplant Interventions: Other: No intervention Sponsors: Paris Translational Research Center for Organ Transplantation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Quantiferon CMV to Identify Treatment Need For Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)
Conditions: Solid Organ Transplantation (Heart, Kidney, Lung, Liver); Cytomegalovirus Infections Interventions: Diagnostic Test: Quantiferon CMV (assay that determine the presence of CMV-specific T lymphocytes).; Other: Communication of the result of the QF-CMV to the clinician in charge Sponsors: University Hospital, Grenoble Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Evaluation of the Prophylactic Use of Letermovir in Kidney Transplant Recipients at Risk of Cytomegalovirus Infection
Conditions: CMV Infection Interventions: Drug: Letermovir 480 MG; Drug: Ganciclovir Sponsors: Hospital do Rim e Hipertens ão Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Transitional ePRO Diary Liver
Conditions: Liver Transplant Sponsors: FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
